Using brain structural neuroimaging measures to predict psychosis onset for individuals at clinical high-risk
Molecular Psychiatry – Zhu Y, Maikusa N, Radua J, Sämann PG, Fusar-Poli P, Agartz I, Andreassen OA, Bachman P, Baeza I, Chen X, Choi S, Corcoran CM, Ebdrup BH, Fortea A, Garani RRG, Glenthøj BY, Glenthøj LB, Haas SS, Hamilton HK, Hayes RA, He Y, Heekeren K, Kasai K, Katagiri N, Kim M, Kristensen TD, Kwon JS, Lawrie SM, Lebedeva I, Lee J, Loewy RL, Mathalon DH, McGuire P, Mizrahi R, Mizuno M, Møller P, Nemoto T, Nordholm D, Omelchenko MA, Raghava JM, Røssberg JI, Rössler W, Salisbury DF, Sasabayashi D, Smigielski L, Sugranyes G, Takahashi T, Tamnes CK, Tang J, Theodoridou A, Tomyshev AS, Uhlhaas PJ, Værnes TG, van Amelsvoort TAMJ, Waltz JA, Westlye LT, Zhou JH, Thompson PM, Hernaus D, Jalbrzikowski M, Koike S, Yuan L, Yamasue H, Wenneberg C, Vinogradov S, Suzuki M, Sørensen ME, Schiffman J, Resch F, Pariente JC, Ouyang L, Nordentoft M, Ma X, Bin Kwak Y, Klaunig MJ, Horton LE, de Haan L, Cho KIK, Chee MWL, Catalano S, Baldwin H, Allen P (2024)
29 (5); 1465-1477